3 times congratulations Annalisa Comandatore and thanks for the great collaboration Marc Besselink Luca Morelli amsterdamumc.org/en/research/in… Cancer Center Amsterdam - Amsterdam UMC

Just published Critical Reviews in Oncology Hematology (CROH) our review on prospects of targeting PI3K/AKT/mTOR #PDAC authors.elsevier.com/a/1fL6a3igGQh2… THANKS to Prof. Firuzi and his team and another Italian Pancreatic Cancer Community I-PCC collaboration with #MiriamMartini

#OpenAccess in Cancer Cell: Detection & localization of early- & late-stage cancers using platelet RNA cell.com/cancer-cell/fu… -99% specificity in asymptomatic controls but only 78% in symptomatic (including benign tumors). - In #PancreaticCancer, stage 2 sensitivity is 40%.

Thanks to Sjors G.J.G. In ’t Veld, Myron G. Best, Thomas Wurdinger and all the coauthors, and special thanks to #CCA and KWFKankerbestrijding for support (for the studies on PDAC)

Our review on the role of the microbiome in PDAC chemoresistance is online: doi.org/10.1016/j.drup…

🗓Join us on December 16th from 14:30 to 15:00 for a special session « (Bio)technology techniques Key Lecture »! Learn more with our expert with our special exhibitor Thermo Fisher. ⏳Hurry up to register #PAMM2022 ➡️ swll.to/Pamm-Registrat… #pharmacology #molecularpathology

#ItsAboutTime Hands on research to improve #PancreaticCancer treatment & raise awareness for #WPCD #amsterdamumc and #FPS W P C C Italian Pancreatic Cancer Community I-PCC Fondazione Nadia Valsecchi Onlus Living With Hope Foundation Pancreatic Cancer Europe (PCE) EPC-Europ Pancr Club AISP Cancer Center Amsterdam - Amsterdam UMC TRANSPAN COST Action

We need to improve the pipeline for biomarker discovery. Clinical consequences of implementing novel tests should prospectively be assessed to determine clinical utility relative to routinely measured markers. Thanks Cancer Center Amsterdam - Amsterdam UMC KWFKankerbestrijding Fondazione AIRC per la ricerca sul cancro #BenninkFoundation

📣 D-2 There are only two days left until the beginning of the 43rd edition of #PAMM2022! 🙌 A high level board will be there to exchange about exciting topics on #pharmacology #immunotherapy and #oncology. ✅ We are waiting for you in Florence!

Thanks Elisa Giovannetti and alll the PAMM - Pharmacology & Molecular Mechanisms Group for the kind invitation. Proud to be part of this multidisciplinary and dynamic EORTC group! Great meeting! Triparna Sen (Sen-Lab)

📣now online our paper on Applications and clinical trial landscape using Toll-like receptor agonists to reduce the toll of cancer. A very interesting topic with a terrific team: ⁦Aung Naing⁩ ⁦Elisa Giovannetti⁩ ⁦Pablo Martinez MD PhD⁩ Shannon McCue nature.com/articles/s4169…

Fibroblasts in pancreatic cancer: molecular and clinical perspectives - now online Trends in Molecular Medicine cell.com/trends/molecul… Thanks Cancer Center Amsterdam - Amsterdam UMC KWFKankerbestrijding #BenninkFoundation Fondazione AIRC per la ricerca sul cancro TRANSPAN COST Action PANDORA CIG Italian Pancreatic Cancer Community I-PCC

Time to celebrate the work of Andrea Valles (and coauthors): Phosphoproteome guiding new drug combinations cell.com/cell-reports/f… Cancer Center Amsterdam - Amsterdam UMC KWFKankerbestrijding Fondazione AIRC per la ricerca sul cancro TRANSPAN COST Action Italian Pancreatic Cancer Community I-PCC

Our Short-term Scientific Stay Award (S3A) 2022 winner, Mjriam Capula, is representing PCE to share her research to improve prevention, early detection, treatment, and care for patients affected by pancreatic cancer at the EPC-Europ Pancr Club meeting in Alpbach. Stay tuned!

Raising awareness on pancreatic cancer day and cancer research in NL & IT Amsterdam UMC FPS @airc_it Fondazione Nadia Valsecchi Onlus Italian Pancreatic Cancer Community I-PCC @KWF_nl Pancreatic Cancer Europe (PCE) EPC-Europ Pancr Club AISP #WPCD to foster together the blossoming of research and cures

Teaching an old dog new tricks: ABCB1 actionable target to combat paclitaxel resistance in PDAC by Bergonzini et al. in Amsterdam Leiden Pisa jeccr.biomedcentral.com/articles/10.11… pubmed.ncbi.nlm.nih.gov/38163893/ Thanks to KWFKankerbestrijding Cancer Center Amsterdam - Amsterdam UMC #FPS Fondazione AIRC per la ricerca sul cancro EORTC for the support and collaboration

📢 Passionnated about #pharmacology and cancer treatments? 💊🧬🎯 Ready to talk about the latest discoveries in this area with experts? 🧠💥 📆 From 7th to 10th of February in #Marseille 👉🏻 here is the link to register lnkd.in/ervjf-rq

🔬 Want to experience an engaging lecture on #PragmaticTrials? Don't miss Dr Denis Lacombe, EORTC CEO, discussing pragmatic clinical trials at the 44th EORTC-PAMM meeting tomorrow in Marseille, France at 9 AM. 👉 For more info: pamm-meeting.com #CancerResearch